Healthcare News: OIG audit targets excessive billing for genetic testing

Article Overview

This article covers an Office of Inspector General review of Medicare Part B genetic testing payments and the broader trend of rapidly increasing spending from 2016 through 2019. It is relevant to coders, compliance staff, laboratory billing teams, and auditors who monitor genetic testing claims, fraud risk, and government enforcement activity. The piece also points readers to the broader set of genetic testing services and the CPT coding areas highlighted in the report, along with the OIG’s ongoing fraud-focused oversight efforts.